Clinical Trial Update: Safety and Efficacy of J147 in Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of J147 for acute ischemic stroke, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• J147

Snippet

Sponsor: Abrexa Pharmaceuticals, Inc. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: NOT_YET_RECRUITING